AlterNet: Drug Deal: "If Congress ratifies Bush's controversial CAFTA bill, pharmaceutical companies will be in for a windfall -- and the casualties will be poor AIDS patients."

...

"CAFTA's intellectual property protections will give monopoly-like status to high-priced, brand-name drugs in poor markets; potentially killing off generics in El Salvador, Nicaragua, Guatemala, Costa Rica, Honduras and the Dominican Republic, and preventing millions of AIDS patients from being able to afford the meds they need."

(Via AlterNet.)